Table 3 Patient-related factors and their impact on discharge day
From: Nonstrict and individual enhanced recovery after surgery (ERAS) in partial hepatectomy
N (%) | Discharge day med (P25–P75) | P value | |
|---|---|---|---|
Gender | |||
Male | 83 (49.40) | 4 (3–7) | 0.592 |
Female | 85 (50.60) | 4 (3–6) | |
Age | |||
16–35 | 15 (8.93) | 4 (4–5) | <0.01 |
36–55 | 56 (33.33) | 4 (3–6) | |
56–75 | 81 (48.21) | 6 (4–7) | |
ASA | |||
1 | 65 (38.69) | 4 (3–6) | <0.001 |
2 | 90 (53.57) | 5 (3–7) | |
3 | 13 (7.74) | 7 (5–9) | |
BMI | |||
<20 | 17 (10.12) | 5 (5–7) | 0.373 |
20–25 | 56 (33.33) | 4 (4–5) | |
25–30 | 84 (50.00) | 5 (3–7) | |
>30 | 11 (6.55) | 5 (3–7) | |
Pathology | |||
Colorectal metastases | 23 (16.07) | 4 (3–6) | 0.503 |
Cholangiocarcinoma | 27 (10.12) | 5 (3–5) | |
Gastrointestinal metastases | 17 (13.10) | 6 (3–7) | |
Hepatocellular carcinoma | 86 (27.38) | 5 (4–7) | |
Others | 15 (8.93) | 5 (3–7) | |
Type | |||
Right hepatectomy | 87 (51.79) | 4 (3–5) | 0.704 |
Left hepatectomy | 66 (39.29) | 4 (3–5) | |
Segmentectomy | 15 (8.93) | 4 (3–6) | |
Co-morbidities | |||
Cirrhosis | 12 (7.14) | 6 (5–9) | <0.001 |
Other | 57 (33.93) | 4 (3–6) | |
No | 99 (58.93) | 4 (3–5) | |